
Explore Aptose Biosciences Inc.'s 8-K filing from February 18, 2025, detailing significant corporate updates. Key info includes market data, contact details, and filing insights.
Explore Aptose Biosciences Inc.'s 8-K filing from February 18, 2025, detailing significant corporate updates. Key info includes market data, contact details, and filing insights.
Discover essential insights from Aptose Biosciences Inc.'s 8-K filing dated February 20, 2025. Key details on common shares, reporting events, and contact info included.
Discover critical insights from Aptose Biosciences Inc.'s 8-K filing dated February 18, 2025. Stay informed on corporate developments impacting APTO stock and shareholder value.
Explore Aptose Biosciences' SEC 8-K filing from February 7, 2025, detailing key updates for investors.
Explore Aptose Biosciences Inc.'s Form 8-K detailing a significant event on February 13, 2025, impacting shareholders and stock performance. Stay informed on biotech developments.
Explore Aptose Biosciences Inc.'s February 2025 Form 8-K report detailing crucial company updates, securities info, and regulatory compliance. Stay informed on APTO's market performance.
Explore APTOSE Biosciences Inc.'s 8-K filing dated January 13, 2025, highlighting crucial events, financial metrics, and insights for investors.
Discover crucial insights from Aptose Biosciences Inc.'s 8-K filing detailing significant events on January 9, 2025. Stay informed on share impacts and corporate developments.
Explore Aptose Biosciences Inc.'s 8-K report filed on December 19, 2024, detailing a significant event impacting shareholders. Discover crucial financial insights and company identifiers.